81 related articles for article (PubMed ID: 17179686)
1. Cost is a barrier to widespread use of liquid-based cytology for cervical cancer screening in Korea.
Chung HH; Kim JW; Kang SB
J Korean Med Sci; 2006 Dec; 21(6):1054-9. PubMed ID: 17179686
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.
Bidus MA; Maxwell GL; Kulasingam S; Rose GS; Elkas JC; Chernofsky M; Myers ER
Obstet Gynecol; 2006 May; 107(5):997-1005. PubMed ID: 16648402
[TBL] [Abstract][Full Text] [Related]
3. Differences among primary care physicians' adherence to 2009 ACOG guidelines for cervical cancer screening.
Corbelli J; Borrero S; Bonnema R; McNamara M; Kraemer K; Rubio D; Karpov I; McNeil M
J Womens Health (Larchmt); 2014 May; 23(5):397-403. PubMed ID: 24380500
[TBL] [Abstract][Full Text] [Related]
4. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
[TBL] [Abstract][Full Text] [Related]
5. The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients.
Wong G; Howard K; Webster A; Chapman JR; Craig JC
Transplantation; 2009 Apr; 87(7):1078-91. PubMed ID: 19352131
[TBL] [Abstract][Full Text] [Related]
6. The influence of cost-effectiveness information on physicians' cancer screening recommendations.
Ubel PA; Jepson C; Baron J; Hershey JC; Asch DA
Soc Sci Med; 2003 Apr; 56(8):1727-36. PubMed ID: 12639589
[TBL] [Abstract][Full Text] [Related]
7. Cervical cytology screening practices among obstetrician-gynecologists.
Noller KL; Bettes B; Zinberg S; Schulkin J
Obstet Gynecol; 2003 Aug; 102(2):259-65. PubMed ID: 12907097
[TBL] [Abstract][Full Text] [Related]
8. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
Perkins RB; Anderson BL; Gorin SS; Schulkin JA
Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024
[TBL] [Abstract][Full Text] [Related]
9. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
[TBL] [Abstract][Full Text] [Related]
10. A survey on pulmonary screening practices among otolaryngology-head & neck surgeons across Canada in the post treatment surveillance of head and neck squamous cell carcinoma.
Madana J; Morand GB; Barona-Lleo L; Black MJ; Mlynarek AM; Hier MP
J Otolaryngol Head Neck Surg; 2015 Feb; 44(1):5. PubMed ID: 25649793
[TBL] [Abstract][Full Text] [Related]
11. Obstetrician-gynecologists' beliefs about performing less cervical cancer screening: the pendulum swings.
Schneider A; Henderson JT; Harper CC; Hsu A; Saraiya M; Sawaya GF
Am J Obstet Gynecol; 2015 Nov; 213(5):744-5. PubMed ID: 26184779
[No Abstract] [Full Text] [Related]
12. Current cervical neoplasia screening practices of obstetrician/gynecologists in the US.
Saint M; Gildengorin G; Sawaya GF
Am J Obstet Gynecol; 2005 Feb; 192(2):414-21. PubMed ID: 15695980
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of cervical-cancer screening in five developing countries.
Goldie SJ; Gaffikin L; Goldhaber-Fiebert JD; Gordillo-Tobar A; Levin C; Mahé C; Wright TC;
N Engl J Med; 2005 Nov; 353(20):2158-68. PubMed ID: 16291985
[TBL] [Abstract][Full Text] [Related]
14. Test ordering for preventive health care among family medicine residents.
Fung D; Schabort I; MacLean CA; Asrar FM; Khory A; Vandermeer B; Allan GM
Can Fam Physician; 2015 Mar; 61(3):256-62. PubMed ID: 25767171
[TBL] [Abstract][Full Text] [Related]
15. Cervix cancer screening in Croatia within the European Cervical Cancer Prevention Week.
Skopljanac-Macina L; Mahovlić V; Ovanin-Rakić A; Barisić A; Rajhvajn S; Juric D; Babić D; Corusić A; Oresković S
Coll Antropol; 2010 Jun; 34(2):613-7. PubMed ID: 20698138
[TBL] [Abstract][Full Text] [Related]
16. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
17. Exploring physicians' views and values in relation to maternal serum screening.
Winquist B; Ogle K; Muhajarine N
J Obstet Gynaecol Can; 2008 Jul; 30(7):564-572. PubMed ID: 18644177
[TBL] [Abstract][Full Text] [Related]
18. The organization of cervical screening in general practice.
Havelock C; Edwards R; Cuzick J; Chamberlain J
J R Coll Gen Pract; 1988 May; 38(310):207-11. PubMed ID: 3210183
[TBL] [Abstract][Full Text] [Related]
19. Obstetric care provider engagement in a perinatal depression screening program.
Kim JJ; La Porte LM; Adams MG; Gordon TE; Kuendig JM; Silver RK
Arch Womens Ment Health; 2009 Jun; 12(3):167-72. PubMed ID: 19277845
[TBL] [Abstract][Full Text] [Related]
20. Variation in recommendations for cancer screening among primary care physicians in New Mexico.
Herman CJ; Hoffman RM; Altobelli KK
J Community Health; 1999 Aug; 24(4):253-67. PubMed ID: 10463470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
